Success Metrics

Active Trials
1(100%)

Phase Distribution

Ph phase_3
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

1

all time

Status Distribution
Active(1)

Detailed Status

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

active_not_recruiting1100%

Recent Activity

1 active trials
Showing 1 of 1
active_not_recruitingphase_3

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

NCT02446444

Clinical Trials (1)

Showing 1 of 1 trials
NCT02446444Phase 3

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Active Not Recruiting

All 1 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
1